During the last decade, evidence has accu-mulated to show that nonalcoholic fatty liver disease (NAFLD) is a ‘multisystem’ disease often associated with obesity and other cardiometabolic disorders. 1 NAFLD increases… Click to show full abstract
During the last decade, evidence has accu-mulated to show that nonalcoholic fatty liver disease (NAFLD) is a ‘multisystem’ disease often associated with obesity and other cardiometabolic disorders. 1 NAFLD increases risk of liver- related complica-tions and increases risk of developing type 2 diabetes (T2D), 2 cardiovascular disease (CVD), 3 chronic kidney disease 4 and certain extrahepatic cancers. 5 Thus, there is now important evidence to support a holistic approach to the treatment of NAFLD in adulthood and that approach extends to risk management of other diseases beyond the liver.
               
Click one of the above tabs to view related content.